Terms ending in 2038
Every in-force patent on Athenex, Inc.'s record whose computed term ends in 2038, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US 10,617,693 | Methods of Treating And/Or Preventing Actinic Keratosis In force · High confidence | Atnx SPV, LLC | In force | High confidence | |
| US 11,497,750 | Methods of Treating And/Or Preventing Actinic Keratosis In force · High confidence | Atnx SPV, LLC | In force | High confidence | |
| US 10,450,303 | Biaryl Piperidine Amide Compounds and Methods of Use Thereof In force · High confidence | Athenex, Inc. | In force | High confidence | |
| US 10,669,236 | Solid Forms of 2-(5-(4-(2-Morpholinoethoxy)PHENYL)PYRIDIN-2-YL)-N-BENZYLACETAMIDE In force · High confidence | Atnx SPV, LLC | In force | High confidence | |
| US 11,230,527 | Solid Forms of 2-(5-(4-(2-Morpholinoethoxy)PHENYL)PYRIDIN-2-YL)-N-BENZYLACETAMIDE In force · Medium confidence | Atnx SPV, LLC | In force | Medium confidence | |
| US 12,215,083 | Solid Forms of 2-(5-(4-(2-Morpholinoethoxy)PHENYL)PYRIDIN-2-YL)-N-BENZYLACETAMIDE In force · Low confidence | Atnx SPV, LLC | In force | Low confidence |
6 of 6 patents shown. Soonest term end first, then patent number.
1 of these is in force and held by Athenex, Inc..
Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.